0001853816 2026-05-22 2026-05-22 0001853816 1 2026-05-22 2026-05-22 0001853816 2 2026-05-22 2026-05-22 0001853816 3 2026-05-22 2026-05-22 0001853816 4 2026-05-22 2026-05-22 0001853816 5 2026-05-22 2026-05-22 0001853816 6 2026-05-22 2026-05-22 0001853816 7 2026-05-22 2026-05-22 0001853816 8 2026-05-22 2026-05-22 0001853816 9 2026-05-22 2026-05-22 0001853816 10 2026-05-22 2026-05-22 0001853816 11 2026-05-22 2026-05-22 0001853816 12 2026-05-22 2026-05-22 iso4217:USD pure S-3 S-3/A EX-FILING FEES 333-291740 0001853816 Dermata Therapeutics, Inc. N/A N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 S-3 Dermata Therapeutics, Inc. Equity Common Stock, par value $0.0001 per share true Equity Preferred Stock, par value $0.0001 per share true Other Warrants true Other Debt Securities true Other Subscription Rights true Other Units true false Unallocated (Universal) Shelf true 5862013.00 0.0001381 809.54 Equity Common Stock, par value $0.0001 per share true S-3 333-268383 2022-11-25 Equity Preferred Stock, par value $0.0001 per share true S-3 333-268383 2022-11-25 Other Warrants true S-3 333-268383 2022-11-25 Other Units true S-3 333-268383 2022-11-25 Unallocated (Universal) Shelf true 10374.01 S-3 333-268383 2022-11-25 94137987.00 5872387.01 809.54 0.00 0.00 809.54 (1) The amount to be registered consists of up to $100,000,000 of an indeterminate amount of common stock, preferred stock, debt securities, warrants, subscription rights and/or units. There is also being registered hereunder such currently indeterminate number of (i) shares of common stock or other securities of the registrant as may be issued upon conversion of, or in exchange for, convertible or exchangeable debt securities and/or preferred stock registered hereby, or (ii) shares of preferred stock, common stock, debt securities, subscription rights or units as may be issued upon exercise of warrants registered hereby, as the case may be. Any securities registered hereunder may be sold separately or as units with the other securities registered hereunder. The securities registered hereunder also include an indeterminate number of securities as may be issued pursuant to anti-dilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also covers any additional securities that may be offered or issued in connection with any stock splits, stock dividends or similar transactions. (2) The proposed maximum aggregate offering price per share will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.ii.b. to Item 16(b) of Form S-3 under the Securities Act. (3) The Registrant previously filed a Registration Statement on Form S-3 with the Securities and Exchange Commission (the "SEC") on November 15, 2022 (File No. 333-268383) (the "Prior Registration Statement"), which was declared effective on November 25, 2022, that registered $100,000,000 of securities to be offered by the Registrant from time to time. Pursuant to Rule 415(a)(6) under the Securities Act, this Registration Statement includes $94,137,987 of unsold securities (the "Unsold Securities") that were previously registered on the Prior Registration Statement. In connection with the registration of the Unsold Securities on the Prior Registration Statement, the Registrant paid a filing fee of $10,374.01 (calculated at the filing fee rate in effect at the time of the filing of the Prior Registration Statement). The Registrant is not required to pay any additional fee with respect to the Unsold Securities being included in this Registration Statement in reliance on Rule 415(a)(6), because such Unsold Securities (and associated fees) are being moved from the Prior Registration Statement to this Registration Statement. Accordingly, the Amount of Registration Fee in the table above reflects only the registration fee attributable to the $5,862,013 of new securities registered on this Registration Statement. The registration fee previously paid by the Registrant relating to the Unsold Securities included on this Registration Statement will continue to be applied to such Unsold Securities. During the grace period afforded by Rule 415(a)(5) under the Securities Act, the Registrant may continue to offer and sell under the Prior Registration Statement the Unsold Securities being registered hereunder. To the extent that, after the filing date hereof and prior to the effectiveness of this Registration Statement, the Registrant sells any such Unsold Securities pursuant to the Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this Registration Statement the updated amount of Unsold Securities from the Prior Registration Statement to be included in this Registration Statement pursuant to Rule 415(a)(6). Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.